Overview

Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
Evaluation of the safety and efficacy of Oxcarbazepine XR as adjunctive treatment for adults with partial onset seizures
Phase:
Phase 3
Details
Lead Sponsor:
Supernus Pharmaceuticals, Inc.
Collaborator:
Parexel
Treatments:
Carbamazepine
Oxcarbazepine